The broad-spectrum antiviral functions of IFIT and IFITM proteins

Nature Reviews Immunology

Volumn 13, Issue 1, 2013, Pages 46-57

  Diamond, Michael S ^a   Farzan, Michael ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CXCL2 CHEMOKINE; INTERFERON; INTERFERON INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEAT PROTEIN; INTERFERON INDUCED TRANSMEMBRANE PROTEIN; INTERLEUKIN 6; MEMBRANE PROTEIN; TETRATRICOPEPTIDE REPEAT PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANTIVIRAL ACTIVITY; CHROMOSOME 7; CYTOPLASM; FLAVIVIRUS; GENE EXPRESSION; HEPATITIS C VIRUS; HUMAN; INFLUENZA VIRUS A; METHYLATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; RNA BINDING; VIRION; VIRUS INFECTION; VIRUS REPLICATION; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, DIFFERENTIATION; ANTIVIRAL AGENTS; CARRIER PROTEINS; HUMANS; INTERFERON INDUCERS; INTERFERONS; MODELS, IMMUNOLOGICAL; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; VIRUS DISEASES; VIRUSES;

EID: 84871484827     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3344     Document Type: Review

References (82)

1. Kawai, T. & Akira, S. Innate immune recognition of viral infection. Nature Immunol. 7, 131-137 (2006).
2. Keating, S. E., Baran, M. & Bowie, A. G. Cytosolic DNA sensors regulating type I interferon induction. Trends Immunol. 32, 574-581 (2011).
3. Theofilopoulos, A. N., Baccala, R., Beutler, B. & Kono, D. H. Type I interferons (a/ß) in immunity and autoimmunity. Annu. Rev. Immunol. 23, 307-336 (2005).
4. Pestka, S., Krause, C. D. & Walter, M. R. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202, 8-32 (2004).
5. Der, S. D., Zhou, A., Williams, B. R. & Silverman, R. H. Identification of genes differentially regulated by interferon a, β, or y using oligonucleotide arrays. Proc. Natl Acad. Sci. USA 95, 15623-15628 (1998).
6. de Veer, M. J. et al. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 69, 912-920 (2001).
7. Lanford, R. E. et al. Genomic response to interferon-a in chimpanzees: implications of rapid downregulation for hepatitis C kinetics. Hepatology 43, 961-972 (2006).
8. Schoggins, J. W. & Rice, C. M. Interferon-stimulated genes and their antiviral effector functions. Curr. Opin. Virol. 1, 519-525 (2011).
9. Hatziioannou, T. & Bieniasz, P. D. Antiretro viral restriction factors. Curr. Opin. Virol. 1, 526-532 (2011).
10. Le Tortorec, A., Willey, S. & Neil, S. J. Antiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteraction. Viruses 3, 520-540 (2011).
11. Skaug, B. & Chen, Z. J. Emerging role of ISG15 in antiviral immunity. Cell 143, 187-190 (2010).
12. Fitzgerald, K. A. The interferon inducible gene: viperin. J. Interferon Cytokine Res. 31, 131-135 (2011).
13. Malim, M. H. & Bieniasz, P. D. HIV restriction factors and mechanisms of evasion. Cold Spring Harb. Perspect. Med. 2, a006940 (2012).
14. Schoggins, J. W. et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472, 481-485 (2011).
15. Karki, S. et al. Multiple interferon stimulated genes synergize with the zinc finger antiviral protein to mediate anti-alphavirus activity. PLoS ONE 7, e37398 (2012).
16. Sen, G. C. & Sarkar, S. N. The interferon-stimulated genes: targets of direct signaling by interferons, double-stranded RNA, and viruses. Curr. Top. Microbiol. Immunol. 316, 233-250 (2007).
17. Fensterl, V & Sen, G. C. The ISG56/IFIT1 gene family. J. Interferon Cytokine Res. 31, 71-78 (2011).
18. Wathelet, M. G., Clauss, I. M., Content, J. & Huez, G. A. The IFI-56K and IFI-54K interferon-inducible human genes belong to the same gene family. FEBS Lett. 231, 164-171 (1988).
19. D'Andrea, L. D. & Regan, L. TPR proteins: the versatile helix. Trends Biochem. Sci. 28, 655-662 (2003).
20. Sarkar, S. N. & Sen, G. C. Novel functions of proteins encoded by viral stress-inducible genes. Pharmacol. Ther. 103, 245-259 (2004).
21. Yang, Z. et al. Crystal structure of ISG54 reveals a novel RNA binding structure and potential functional mechanisms. Cell Res. 22, 1328-1338 (2012).
22. Daffis, S., Samuel, M. A., Keller, B. C., Gale, M. Jr & Diamond, M. S. Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and independent mechanisms. PLoS Pathog. 3, e106 (2007).
23. Levy, D., Larner, A., Chaudhuri, A., Babiss, L. E. & Darnell, J. E. Jr. Interferon-stimulated transcription: isolation of an inducible gene and identification of its regulatory region. Proc. Natl Acad. Sci. USA 83, 8929-8933 (1986).
24. Bluyssen, H. A. et al. Structure, chromosome localization, and regulation of expression of the interferon-regulated mouse Ifi54/Ifi56 gene family. Genomics 24, 137-148 (1994).
25. de Veer, M. J., Sim, H., Whisstock, J. C., Devenish, R. J. & Ralph, S. J. IFI60/ISG60/IFIT4, a new member of the human IFI54/IFIT2 family of interferon-stimulated genes. Genomics 54, 267-277 (1998).
26. Kusari, J. & Sen, G. C. Regulation of synthesis and turnover of an interferon-inducible mRNA. Mol. Cell. Biol. 6, 2062-2067 (1986).
27. Terenzi, F., Hui, D. J., Merrick, W. C. & Sen, G. C. Distinct induction patterns and functions of two closely related interferon-inducible human genes, ISG54 and ISG56. J. Biol. Chem. 281, 34064-34071 (2006).
28. Terenzi, F., White, C., Pal, S., Williams, B. R. & Sen, G. C. Tissue-specific and inducer-specific differential induction of ISG56 and ISG54 in mice. J. Virol. 81, 8656-8665 (2007).
29. Wacher, C. et al. Coordinated regulation and widespread cellular expression of interferon-stimulated genes (ISG) ISG-49, ISG-54, and ISG-56 in the central nervous system after infection with distinct viruses. J. Virol. 81, 860-871 (2007).
30. Fensterl, V., White, C. L., Yamashita, M. & Sen, G. C. Novel characteristics of the function and induction of murine p56 family proteins. J. Virol. 82, 11045-11053 (2008).
31. Grandvaux, N. et al. Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J. Virol. 76, 5532-5539 (2002).
32. Ogawa, S. et al. Molecular determinants of crosstalk between nuclear receptors and Toll-like receptors. Cell 122, 707-721 (2005).
33. Barnes, B. J. et al. Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection. J. Biol. Chem. 279, 45194-45207 (2004).
34. Lou, Y. J. et al. IRF-9/STAT2 functional interaction drives retinoic acid-induced gene G expression independently of STAT1. Cancer Res. 69, 3673-3680 (2009).
35. Yu, M. et al. Cloning of a gene (RIG-G) associated with retinoic acid-induced differentiation of acute promyelocytic leukemia cells and representing a new member of a family of interferon-stimulated genes. Proc. Natl Acad. Sci. USA 94, 7406-7411 (1997).
36. Hinnebusch, A. G. eIF3: a versatile scaffold for translation initiation complexes. Trends Biochem. Sci. 31, 553-562 (2006).
37. Guo, J., Peters, K. L. & Sen, G. C. Induction of the human protein P56 by interferon, double-stranded RNA, or virus infection. Virology 267, 209-219 (2000).
38. Hui, D. J., Bhasker, C. R., Merrick, W. C. & Sen, G. C. Viral stress-inducible protein p56 inhibits translation by blocking the interaction of eIF3 with the ternary complex eIF2.GTP.Met-tRNAi. J. Biol. Chem. 278, 39477-39482 (2003).
39. Otto, G. A. & Puglisi, J. D. The pathway of HCV IRES-mediated translation initiation. Cell 119, 369-380 (2004).
40. Sumpter, R. et al. Viral evolution and interferon resistance of hepatitis C virus RNA replication in a cell culture model. J. Virol. 78, 11591-11604 (2004).
41. Wang, C. et al. Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication. J. Virol. 77, 3898-3912 (2003).
42. Raychoudhuri, A. et al. ISG56 and IFITM1 proteins inhibit hepatitis C virus replication. J. Virol. 85, 12881-12889 (2011).
43. Wei, C. M., Gershowitz, A. & Moss, B. Methylated nucleotides block 5' terminus of HeLa cell messenger RNA. Cell 4, 379-386 (1975).
44. Wei, C. M. & Moss, B. Methylated nucleotides block 5'-terminus of vaccinia virus messenger RNA. Proc. Natl Acad. Sci. USA 72, 318-322 (1975).
45. Daffis, S. et al. 2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 468, 452-456 (2010).
46. Szretter, K. J. et al. 2'-O methylation of the viral mRNA cap by West Nile virus evades Ifit1-dependent and-independent mechanisms of host restriction in vivo. PLoS Pathog. 8, e1002698 (2012).
47. Zust, R. et al. Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nature Immunol. 12, 137-143 (2011).
48. Hefti, E., Bishop, D. H., Dubin, D. T. & Stollar, V. 5' nucleotide sequence of sindbis viral RNA. J. Virol. 17, 149-159 (1975).
49. Zhang, Y., Burke, C. W., Ryman, K. D. & Klimstra, W. B. Identification and characterization of interferon-induced proteins that inhibit alphavirus replication. J. Virol. 81, 11246-11255 (2007).
50. Pichlmair, A. et al. IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA. Nature Immunol. 12, 624-630 (2011).
51. Fensterl, V. et al. Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. PLoS Pathog. 8, e1002712 (2012).
52. Schmeisser, H. et al. Identification of α interferon-induced genes associated with antiviral activity in Daudi cells and characterization of IFIT3 as a novel antiviral gene. J. Virol. 84, 10671-10680 (2010).
53. Terenzi, F., Saikia, P. & Sen, G. C. Interferon-inducible protein, P56, inhibits HPV DNA replication by binding to the viral protein E1. EMBO J. 27, 3311-3321 (2008).
54. Saikia, P., Fensterl, V. & Sen, G. C. The inhibitory action of P56 on select functions of E1 mediates interferon's effect on human papillomavirus DNA replication. J. Virol. 84, 13036-13039 (2010).
55. Berchtold, S. et al. Forced IFIT-2 expression represses LPS induced TNF-α expression at posttranscriptional levels. BMC Immunol. 9, 75 (2008).
56. Li, Y. et al. ISG56 is a negative-feedback regulator of virus-triggered signaling and cellular antiviral response. Proc. Natl Acad. Sci. USA 106, 7945-7950 (2009).
57. McDermott, J. E. et al. Identification and validation of Ifit1 as an important innate immune bottleneck. PLoS ONE 7, e36465 (2012).
58. Liu, X. Y., Chen, W., Wei, B., Shan, Y. F. & Wang, C. IFN-induced TPR protein IFIT3 potentiates antiviral signaling by bridging MAVS and TBK1. J. Immunol. 187, 2559-2568 (2011).
59. Wang, B. X., Rahbar, R. & Fish, E. N. Interferon: current status and future prospects in cancer therapy. J. Interferon Cytokine Res. 31, 545-552 (2011).
60. Xiao, S. et al. RIG-G as a key mediator of the antiproliferative activity of interferon-related pathways through enhancing p21 and p27 proteins. Proc. Natl Acad. Sci. USA 103, 16448-16453 (2006).
61. Hsu, Y. A. et al. A novel interaction between interferon-inducible protein p56 and ribosomal protein L15 in gastric cancer cells. DNA Cell Biol. 30, 671-679 (2011).
62. Stawowczyk, M., Van Scoy, S., Kumar, K. P. & Reich, N. C. The interferon stimulated gene 54 promotes apoptosis. J. Biol. Chem. 286, 7257-7266 (2011).
63. Hickford, D., Frankenberg, S., Shaw, G. & Renfree, M. B. Evolution of vertebrate interferon inducible transmembrane proteins. BMC Genomics 13, 155 (2012).
64. Yount, J. S. et al. Palmitoylome profiling reveals S-palmitoylation- dependent antiviral activity of IFITM3. Nature Chem. Biol. 6, 610-614 (2010).
65. Yount, J. S., Karssemeijer, R. A. & Hang, H. C. S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus. J. Biol. Chem. 287, 19631-19641 (2012).
66. Tanaka, S. S., Yamaguchi, Y. L., Tsoi, B., Lickert, H. & Tam, P. P. IFITM/Mil/fragilis family proteins IFITM1 and IFITM3 play distinct roles in mouse primordial germ cell homing and repulsion. Dev. Cell 9, 745-756 (2005).
67. Jaffe, E. A. et al. IFN-γ and IFN-α induce the expression and synthesis of Leu 13 antigen by cultured human endothelial cells. J. Immunol. 143, 3961-3966 (1989).
68. Lewin, A. R., Reid, L. E., McMahon, M., Stark, G. R. & Kerr, I. M. Molecular analysis of a human interferon-inducible gene family. Eur. J. Biochem. 199, 417-423 (1991).
69. Takahashi, S., Doss, C., Levy, S. & Levy, R. TAPA-1, the target of an antiproliferative antibody, is associated on the cell surface with the Leu-13 antigen. J. Immunol. 145, 2207-2213 (1990).
70. Bradbury, L. E., Goldmacher, V. S. & Tedder, T. F. The CD19 signal transduction complex of B lymphocytes. Deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu 13. J. Immunol. 151, 2915-2927 (1993).
71. Lange, U. C. et al. Normal germ line establishment in mice carrying a deletion of the Ifitm/Fragilis gene family cluster. Mol. Cell. Biol. 28, 4688-4696 (2008).
72. Brass, A. L. et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139, 1243-1254 (2009).
73. Feeley, E. M. et al. IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog. 7, e1002337 (2011).
74. Huang, I. C. et al. Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog. 7, e1001258 (2011).
75. Chan, Y. K., Huang, I. C. & Farzan, M. IFITM proteins restrict antibody-dependent enhancement of Dengue virus infection. PLoS ONE 7, e34508 (2012).
76. Jiang, D. et al. Identification of five interferon-induced cellular proteins that inhibit West Nile virus and dengue virus infections. J. Virol. 84, 8332-8341 (2010).
77. Lu, J. et al. The IFITM proteins inhibit HIV-1 infection. J. Virol. 85, 2126-2137 (2011).
78. Everitt, A. R. et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484, 519-523 (2012).
79. Bailey, C. C., Huang, I. C., Kam, C. & Farzan, M. Ifitm3 limits the severity of acute influenza in mice. PLoS Pathog. 8, e1002909 (2012).
80. Wee, Y. S., Roundy, K. M., Weis, J. J. & Weis, J. H. Interferon-inducible transmembrane proteins of the innate immune response act as membrane organizers by influencing clathrin and v-ATPase localization and function. Innate Immun. 18, 834-845 (2012).
81. Ablasser, A. & Hornung, V. Where, in antiviral defense, does IFIT1 fit? Nature Immunol. 12, 588-590 (2011).
82. Radoshitzky, S. R. et al. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 446, 92-96 (2007).